Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abcam plc stock logo
ABCZF
Abcam
C$22.25
C$22.25
C$5.00
C$23.80
N/AN/A2,659 shsN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
$0.00
$0.00
$0.00
N/AN/A11,650 shsN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
$0.00
$0.00
$0.07
N/AN/A1.28 million shsN/A
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
C$10.98
-7.5%
C$10.65
C$4.55
C$13.93
C$881.39MN/A216,990 shs528,177 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abcam plc stock logo
ABCZF
Abcam
0.00%0.00%0.00%0.00%0.00%
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
0.00%0.00%0.00%0.00%0.00%
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
-4.71%-7.42%+18.45%+41.76%+149.69%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abcam plc stock logo
ABCZF
Abcam
C$22.25
C$22.25
C$5.00
C$23.80
N/AN/A2,659 shsN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
$0.00
$0.00
$0.00
N/AN/A11,650 shsN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
$0.00
$0.00
$0.07
N/AN/A1.28 million shsN/A
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
C$10.98
-7.5%
C$10.65
C$4.55
C$13.93
C$881.39MN/A216,990 shs528,177 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abcam plc stock logo
ABCZF
Abcam
0.00%0.00%0.00%0.00%0.00%
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
0.00%0.00%0.00%0.00%0.00%
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
-4.71%-7.42%+18.45%+41.76%+149.69%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abcam plc stock logo
ABCZF
Abcam
0.00
N/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
0.00
N/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
0.00
N/AN/AN/A
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
2.00
HoldN/AN/A

Current Analyst Ratings Breakdown

Latest GLASF, FFNTF, ATTBF, and ABCZF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/15/2026
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
UpgradeHold
(Data available from 6/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abcam plc stock logo
ABCZF
Abcam
N/AN/AN/AN/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/AN/AN/AN/AN/AN/A
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abcam plc stock logo
ABCZF
Abcam
N/AC$0.17130.73N/AN/AN/AN/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/A-$0.16N/AN/AN/AN/AN/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
N/AN/AN/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abcam plc stock logo
ABCZF
Abcam
C$0.070.32%N/A42.48%N/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/AN/AN/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/AN/AN/AN/AN/A
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Abcam plc stock logo
ABCZF
Abcam
43.58%
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
32.45%
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/A
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
N/A

Insider Ownership

CompanyInsider Ownership
Abcam plc stock logo
ABCZF
Abcam
N/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/A
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Abcam plc stock logo
ABCZF
Abcam
1,750N/AN/ANot Optionable
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/AN/AN/ANot Optionable
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
460N/AN/ANot Optionable
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
36280.27 millionN/ANot Optionable

Recent News About These Companies

Glass House Brands Provides Notice of Warrant Acceleration
Glass House Brands Provides Notice of Warrant Acceleration
Glass House Brands Pursues NYSE Listing Path

New MarketBeat Followers Over Time

Media Sentiment Over Time

Abcam stock logo

Abcam OTCMKTS:ABCZF

C$22.25 0.00 (0.00%)
As of 06/23/2026

Abcam Limited, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. Abcam Limited was formerly known as Abcam plc and changed its name to Abcam Limited in December 2023. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. As of December 6, 2023, Abcam Limited operates as a subsidiary of Danaher Corporation.

Abattis Bioceuticals stock logo

Abattis Bioceuticals OTCMKTS:ATTBF

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.

4Front Ventures stock logo

4Front Ventures OTCMKTS:FFNTF

4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. The company operates through THC Cannabis and CBD Wellness segments. THC Cannabis segment engages in the cultivation, production, manufacturing, and distribution of THC cannabis products to owned dispensaries and third party retailers; and provision of ancillary services. This segment sells equipment, supplies, and intellectual property to cannabis producers; and leases real estate properties. The CBD Wellness segment sells non-THC hemp derived products. In addition, it operates dispensaries in the Massachusetts, Illinois, and Michigan primarily under the MISSION brand name. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona.

Glass House Brands stock logo

Glass House Brands OTCMKTS:GLASF

C$10.98 -0.89 (-7.50%)
As of 03:59 PM Eastern

Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. The company operates in three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods. It cultivates, manufactures, and distributes cannabis bulk flowers and trims to wholesalers; and consumer packaged goods to third-party retail stores in California. The company also owns and operates retail cannabis stores. In addition, it offers raw cannabis, cannabis oil, and cannabis consumer goods; edibles; flower jars and bags; single, multi-pack, and infused pre-rolls; tinctures; biomass for distributors; and online payment processing, in-store pickup and home delivery services for adult-use and medicinal-use customers. The company offers its cannabis products under the Glass House Farms, FIELD, Forbidden Flowers, PLUS, Mama Sue, Allswell, and REEFORM brand names. Glass House Brands Inc. was founded in 2015 and is headquartered in Long Beach, California.